Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
TRPM7 kinase is required for insulin production and compensatory islet responses during obesity
Noushafarin Khajavi, … , Susanna Zierler, Thomas Gudermann
Noushafarin Khajavi, … , Susanna Zierler, Thomas Gudermann
Published December 27, 2022
Citation Information: JCI Insight. 2023;8(3):e163397. https://doi.org/10.1172/jci.insight.163397.
View: Text | PDF
Research Article Cell biology

TRPM7 kinase is required for insulin production and compensatory islet responses during obesity

  • Text
  • PDF
Abstract

Most overweight individuals do not develop diabetes due to compensatory islet responses to restore glucose homeostasis. Therefore, regulatory pathways that promote β cell compensation are potential targets for treatment of diabetes. The transient receptor potential cation channel subfamily M member 7 protein (TRPM7), harboring a cation channel and a serine/threonine kinase, has been implicated in controlling cell growth and proliferation. Here, we report that selective deletion of Trpm7 in β cells disrupted insulin secretion and led to progressive glucose intolerance. We indicate that the diminished insulinotropic response in β cell–specific Trpm7-knockout mice was caused by decreased insulin production because of impaired enzymatic activity of this protein. Accordingly, high-fat–fed mice with a genetic loss of TRPM7 kinase activity displayed a marked glucose intolerance accompanied by hyperglycemia. These detrimental glucoregulatory effects were engendered by reduced compensatory β cell responses because of mitigated protein kinase B (AKT)/ERK signaling. Collectively, our data identify TRPM7 kinase as a potentially novel regulator of insulin synthesis, β cell dynamics, and glucose homeostasis under obesogenic diet.

Authors

Noushafarin Khajavi, Andreas Beck, Klea Riçku, Philipp Beyerle, Katharina Jacob, Sabrina F. Syamsul, Anouar Belkacemi, Peter S. Reinach, Pascale C.F. Schreier, Houssein Salah, Tanja Popp, Aaron Novikoff, Andreas Breit, Vladimir Chubanov, Timo D. Müller, Susanna Zierler, Thomas Gudermann

×

Figure 8

TRPM7 kinase disruption reduces compensatory β cell responses due to a mitigated AKT/ERK signaling.

Options: View larger image (or click on image) Download as PowerPoint
TRPM7 kinase disruption reduces compensatory β cell responses due to a m...
(A) Number of islets per pancreatic cryosection (n = 144 slides, 3 mice per genotype), (B) relative frequency plot of islet diameter comparing WT with Trpm7R/R islets (n = 144 slides, 6 mice per genotype). (C) Pancreas weight of WT and Trpm7R/R mice maintained on an HFD for approximately 16 weeks (n = 5 mice per genotype). (D) β Cell size (≥10 islets, at least 3 mice per genotype) and (E) percentage of Ki67-positive cells from the population (100%) of the insulin-positive cells per pancreatic islet in WT and Trpm7R/R mice under the chow or HFD for 16 weeks (n = 20, 5 mice per genotype). (F) Confocal images of WT and Trpm7R/R islets stained for DAPI (blue), insulin (green), and Ki67 (red). The scale bar represents 100 μm. (G) For RNA-Seq analysis, islet RNA was collected from Trpm7R/R mice and the control littermates that had been maintained on an HFD for approximately 16 weeks (n = 3 mice per genotype, age: ~24 weeks). Volcano plot with downregulated and upregulated genes. Differentially expressed genes (DEGs) were identified (P < 0.05) by using EdgeR method. DEGs are expressed as log2 fold change over control with an adjusted P value for each gene. (H) Assessment of the activity of the cell signaling molecules SMAD2, SMAD4, ERK1/2, and AKT using Bio-Plex assay and phospho-specific antibodies on lysates of isolated islets from WT and Trpm7R/R mice (n = 10, measured in duplicates, 10 mice per genotype) under 16 weeks of HFD. Data are normalized to Tubulin content. Data show means ± SEM and statistical differences were assessed by Mann-Whitney test (A) or unpaired 2-tailed Student’s t test (B–E, and H). Circles in bar graphs represent single values. P values are shown above the bars.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts